FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: Yu. M. Lopatin
Формат: Artigo
Язык:Inglês
Опубликовано: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Серии:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Предметы:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Online-ссылка:https://www.rpcardio.com/jour/article/view/1052
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы